Combining top-ranked immunotherapeutics in lung cancer
نویسندگان
چکیده
منابع مشابه
Human Vaccines & Immunotherapeutics awards Top Reviewer of the Year
In its 9th year of publication Human Vaccines & Immunotherapeutics (HV&I) has become well-established in the vaccine community as an important forum for academics, companies, governmental and non-governmental organizations in this field. Our journal contains a mix of highquality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. Its u...
متن کاملTop-k Ranked Document Search in General Text Databases
Text search engines return a set of k documents ranked by similarity to a query. Typically, documents and queries are drawn from natural language text, which can readily be partitioned into words, allowing optimizations of data structures and algorithms for ranking. However, in many new search domains (DNA, multimedia, OCR texts, Far East languages) there is often no obvious definition of words...
متن کاملTop-ranked Proteins and Related Pathways in Humans and Plants
Somatic mutation of signal transduction genes or key nodes of the cellular protein network can cause severe diseases in humans but can sometimes genetically improve plants, likely because growth is determinate in animals but indeterminate in plants. This article reviews protein networks; human protein ranking; the mitogenactivated protein kinase (MAPK) and insulin (phosphoinositide 3kinase [PI3...
متن کاملVaccine adjuvants as potential cancer immunotherapeutics
Accumulated evidence obtained from various clinical trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund's adjuvant, because of either a lack of potent anti-tumor immunity or the induction of undesired immunity. Several clinical trials using immunostimulatory adjuvan...
متن کاملPhytochemicals Approach for Developing Cancer Immunotherapeutics
Phytochemicals or their derived compounds are being increasingly recognized as potentially potent complementary treatments for cancer. Among them, some phytochemicals are being actively evaluated for use as adjuvants in anticancer therapies. For instance, shikonin and hypericin were found to induce immunogenic cell death of specific cancer cells, and this effect was able to further activate the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Oncology
سال: 2018
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(18)30186-4